EL
ELV
HealthcareElevance Health, Inc.
Healthcare Plans
Total Trades
37
Unique Traders
9
Purchases / Sales
19/18
News Articles
5
Trading History
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Apr 13, 2026 |  Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $316.07 | $399.64 | +26.4% | +18.2% | |
Mar 30, 2026 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $284.79 | $376.63 | +32.2% | +19.7% | |
Feb 24, 2026 | Rohit KhannaD | Stock | Buy | $15,001 - $50,000 | $325.14 | $296.09 | -8.9% | -4.8% | |
Feb 17, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $342.67 | $291.15 | -15.0% | -11.7% | |
Jan 29, 2026 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $344.85 | $318.04 | -7.8% | -6.6% | |
Jan 23, 2026 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $368.79 | $340.83 | -7.6% | -7.6% | |
Nov 3, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $309.68 | $327.04 | +5.6% | +5.5% | |
Oct 27, 2025 |  Michael T. McCaulR | Stock | Sell | $15,001 - $50,000 | $338.65 | $334.72 | -1.2% | -0.3% | |
Sep 29, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $316.10 | $332.59 | +5.2% | +1.6% | |
Sep 5, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $308.44 | $346.57 | +12.4% | +8.7% | |
Aug 26, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $306.77 | $315.08 | +2.7% | +0.4% | |
Aug 21, 2025 | Michael T. McCaulR | Stock | Buy | $15,001 - $50,000 | $306.34 | $312.10 | +1.9% | -2.8% | |
Aug 13, 2025 |  Lisa McClainR | Stock | Sell | $1,001 - $15,000 | $291.33 | $310.16 | +6.5% | +4.5% | |
Aug 5, 2025 |  Gilbert CisnerosD | Stock | Buy | $1,001 - $15,000 | $273.50 | $304.81 | +11.4% | +8.1% | |
Aug 4, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $272.04 | $318.20 | +17.0% | +15.0% | |
Jul 25, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $286.06 | $313.22 | +9.5% | +8.2% | |
Jul 10, 2025 | Lisa McClainR | Stock | Buy | $1,001 - $15,000 | $342.22 | $290.90 | -15.0% | -16.8% | |
Jun 24, 2025 | Lisa McClainR | Stock | Buy | $1,001 - $15,000 | $372.46 | $277.48 | -25.5% | -30.1% | |
Jun 20, 2025 | Michael T. McCaulR | Stock | Sell | $15,001 - $50,000 | $370.58 | $274.17 | -26.0% | -31.6% | |
May 30, 2025 | Gilbert CisnerosD | Stock | Sell | $1,001 - $15,000 | $378.13 | $377.47 | -0.2% | -4.8% | |
May 28, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $372.33 | $377.47 | +1.4% | -3.6% | |
May 19, 2025 | Rohit KhannaD | Stock | Sell | $1,001 - $15,000 | $397.81 | $371.95 | -6.5% | -6.9% | |
May 15, 2025 |  Rob BresnahanR | Stock | Sell | $15,001 - $50,000 | $381.85 | $378.17 | -1.0% | -2.1% | |
May 12, 2025 |  Jefferson ShreveR | Stock | Sell | $15,001 - $50,000 | $407.98 | $374.61 | -8.2% | -11.3% | |
Apr 29, 2025 | Gilbert CisnerosD | Stock | Buy | $1,001 - $15,000 | $405.00 | $372.58 | -8.0% | -14.5% | |
Apr 11, 2025 |  Dan NewhouseR | Stock | Sell | $1,001 - $15,000 | $430.62 | $396.12 | -8.0% | -13.7% | |
Mar 12, 2025 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $402.45 | $430.62 | +7.0% | +11.2% | |
Mar 10, 2025 |  Jared MoskowitzD | Stock | Sell | $1,001 - $15,000 | $400.99 | $426.57 | +6.4% | +8.2% | |
Mar 10, 2025 | Jared MoskowitzD | Stock | Sell | $1,001 - $15,000 | $400.99 | $426.57 | +6.4% | +8.2% | |
Feb 24, 2025 | Jefferson ShreveR | Stock | Buy | $15,001 - $50,000 | $377.95 | $424.13 | +12.2% | +16.7% | |
Jan 13, 2025 | Rob BresnahanR | Stock | Sell | $1,001 - $15,000 | $388.96 | $378.34 | -2.7% | -6.5% | |
Jan 9, 2025 | Michael T. McCaulR | Stock | Sell | $15,001 - $50,000 | $375.96 | $383.99 | +2.1% | +0.2% | |
Dec 18, 2024 | Rohit KhannaD | Stock | Buy | $1,001 - $15,000 | $359.31 | $377.98 | +5.2% | +2.9% | |
Dec 16, 2024 | Rohit KhannaD | Stock | Buy | $15,001 - $50,000 | $366.21 | $381.90 | +4.3% | +6.3% | |
Oct 29, 2024 |  Valerie HoyleD | Stock | Buy | $1,001 - $15,000 | $401.14 | $393.49 | -1.9% | -4.8% | |
Mar 25, 2024 | Michael T. McCaulR | Stock | Sell | $50,001 - $100,000 | $495.63 | $518.33 | +4.6% | +7.3% |
Recent News
Jefferies Maintains Buy on Elevance Health, Lowers Price Target to $391
Benzinga-Invalid Date
Stay Ahead of the Game With Elevance Health (ELV) Q1 Earnings: Wall Street's Insights on Key Metrics
Yahoo-Invalid Date
Will Health Benefits Weakness Drag Elevance's Q1 Earnings?
Yahoo-Invalid Date
California judge tosses Elevance’s surprise billing suit in win for providers
Yahoo-Invalid Date
Truist Securities Maintains Buy on Elevance Health, Lowers Price Target to $375
Benzinga-Invalid Date